Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis

Elizabeth Papalardo, Zurina Romay-Penabad, Rohan Willis, Premkumar Christadoss, Ana Laura Carrera-Marin, Elba Reyes-Maldonado, Rajani Rudrangi, Silvana Alfieri-Papalardo, Ethel Garcia-Latorre, Miri Blank, Silvia Pierangeli, Allan R. Brasier, Emilio Gonzalez

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: Both environmental and genetic factors are important in the development of antiphospholipid antibodies (aPL) in patients with antiphospholipid syndrome (APS). Currently, the only available data on predisposing genetic factors have been obtained from epidemiologic studies, without mechanistic evidence. Therefore, we studied the influence of major histocompatibility complex (MHC) class II alleles on the production of aPL in a mouse model of APS. Methods: Three groups of mice, MHC class II–deficient (MHCII−/−) mice, MHCII−/− mice transgenic for human HLA–DQ6 (DQ6), DQ8, or DR4 alleles, and the corresponding wild-type (WT) mouse strains were immunized; half were immunized with human β2-glycoprotein I (β2GPI), and the other half were immunized with control ovalbumin (OVA) protein. Thrombus formation in vivo, tissue factor activity in carotid and peritoneal macrophages, and serum levels of tumor necrosis factor (TNF), IgG anticardiolipin (aCL), antibodies, and anti-OVA antibodies were determined. Results: Immunization with β2GPI induced significant production of aCL and anti-β2GPI in WT mice compared with control mice immunized with OVA (P < 0.001) but diminished aCL (P < 0.001) and anti-β2GPI (P = 0.016) production in MHCII−/− mice. Anti-β2GPI production was fully restored in DQ6 and DQ8 mice, while levels of anti-β2GPI in DR4 mice and aCL in all transgenic lines were only partially restored (P < 0.001 to P < 0.046). Thrombus size in WT mice was twice that in MHCII−/− mice (P < 0.001) but similar to that in all transgenic lines. Carotid and peritoneal macrophage tissue factor levels decreased by >50% in MHCII−/− mice compared with wild-type B6 mice and were restored in DQ8 mice but not DR4 mice or DQ6 mice. TNF levels decreased 4-fold in MHCII−/− mice (P < 0.001) and were not restored in transgenic mice. Conclusion: Our mechanistic study is the first to show that MHC class II alleles influence not only quantitative aPL production but also the pathogenic capacity of induced aPL.

Original languageEnglish (US)
Pages (from-to)2052-2061
Number of pages10
JournalArthritis and Rheumatology
Volume69
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Antiphospholipid Antibodies
Major Histocompatibility Complex
Thrombosis
Alleles
Ovalbumin
Glycoproteins
Antiphospholipid Syndrome
Transgenic Mice
Tumor Necrosis Factor-alpha
Anticardiolipin Antibodies
Peritoneal Macrophages
Thromboplastin
Causality
Antibody Formation
Epidemiologic Studies
Anti-Idiotypic Antibodies
Immunization
Immunoglobulin G

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis. / Papalardo, Elizabeth; Romay-Penabad, Zurina; Willis, Rohan; Christadoss, Premkumar; Carrera-Marin, Ana Laura; Reyes-Maldonado, Elba; Rudrangi, Rajani; Alfieri-Papalardo, Silvana; Garcia-Latorre, Ethel; Blank, Miri; Pierangeli, Silvia; Brasier, Allan R.; Gonzalez, Emilio.

In: Arthritis and Rheumatology, Vol. 69, No. 10, 01.10.2017, p. 2052-2061.

Research output: Contribution to journalArticle

Papalardo, E, Romay-Penabad, Z, Willis, R, Christadoss, P, Carrera-Marin, AL, Reyes-Maldonado, E, Rudrangi, R, Alfieri-Papalardo, S, Garcia-Latorre, E, Blank, M, Pierangeli, S, Brasier, AR & Gonzalez, E 2017, 'Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis', Arthritis and Rheumatology, vol. 69, no. 10, pp. 2052-2061. https://doi.org/10.1002/art.40195
Papalardo, Elizabeth ; Romay-Penabad, Zurina ; Willis, Rohan ; Christadoss, Premkumar ; Carrera-Marin, Ana Laura ; Reyes-Maldonado, Elba ; Rudrangi, Rajani ; Alfieri-Papalardo, Silvana ; Garcia-Latorre, Ethel ; Blank, Miri ; Pierangeli, Silvia ; Brasier, Allan R. ; Gonzalez, Emilio. / Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis. In: Arthritis and Rheumatology. 2017 ; Vol. 69, No. 10. pp. 2052-2061.
@article{4d3ee723a13f4c59887ae64c802d9108,
title = "Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis",
abstract = "Objective: Both environmental and genetic factors are important in the development of antiphospholipid antibodies (aPL) in patients with antiphospholipid syndrome (APS). Currently, the only available data on predisposing genetic factors have been obtained from epidemiologic studies, without mechanistic evidence. Therefore, we studied the influence of major histocompatibility complex (MHC) class II alleles on the production of aPL in a mouse model of APS. Methods: Three groups of mice, MHC class II–deficient (MHCII−/−) mice, MHCII−/− mice transgenic for human HLA–DQ6 (DQ6), DQ8, or DR4 alleles, and the corresponding wild-type (WT) mouse strains were immunized; half were immunized with human β2-glycoprotein I (β2GPI), and the other half were immunized with control ovalbumin (OVA) protein. Thrombus formation in vivo, tissue factor activity in carotid and peritoneal macrophages, and serum levels of tumor necrosis factor (TNF), IgG anticardiolipin (aCL), antibodies, and anti-OVA antibodies were determined. Results: Immunization with β2GPI induced significant production of aCL and anti-β2GPI in WT mice compared with control mice immunized with OVA (P < 0.001) but diminished aCL (P < 0.001) and anti-β2GPI (P = 0.016) production in MHCII−/− mice. Anti-β2GPI production was fully restored in DQ6 and DQ8 mice, while levels of anti-β2GPI in DR4 mice and aCL in all transgenic lines were only partially restored (P < 0.001 to P < 0.046). Thrombus size in WT mice was twice that in MHCII−/− mice (P < 0.001) but similar to that in all transgenic lines. Carotid and peritoneal macrophage tissue factor levels decreased by >50{\%} in MHCII−/− mice compared with wild-type B6 mice and were restored in DQ8 mice but not DR4 mice or DQ6 mice. TNF levels decreased 4-fold in MHCII−/− mice (P < 0.001) and were not restored in transgenic mice. Conclusion: Our mechanistic study is the first to show that MHC class II alleles influence not only quantitative aPL production but also the pathogenic capacity of induced aPL.",
author = "Elizabeth Papalardo and Zurina Romay-Penabad and Rohan Willis and Premkumar Christadoss and Carrera-Marin, {Ana Laura} and Elba Reyes-Maldonado and Rajani Rudrangi and Silvana Alfieri-Papalardo and Ethel Garcia-Latorre and Miri Blank and Silvia Pierangeli and Brasier, {Allan R.} and Emilio Gonzalez",
year = "2017",
month = "10",
day = "1",
doi = "10.1002/art.40195",
language = "English (US)",
volume = "69",
pages = "2052--2061",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of Thrombosis

AU - Papalardo, Elizabeth

AU - Romay-Penabad, Zurina

AU - Willis, Rohan

AU - Christadoss, Premkumar

AU - Carrera-Marin, Ana Laura

AU - Reyes-Maldonado, Elba

AU - Rudrangi, Rajani

AU - Alfieri-Papalardo, Silvana

AU - Garcia-Latorre, Ethel

AU - Blank, Miri

AU - Pierangeli, Silvia

AU - Brasier, Allan R.

AU - Gonzalez, Emilio

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Objective: Both environmental and genetic factors are important in the development of antiphospholipid antibodies (aPL) in patients with antiphospholipid syndrome (APS). Currently, the only available data on predisposing genetic factors have been obtained from epidemiologic studies, without mechanistic evidence. Therefore, we studied the influence of major histocompatibility complex (MHC) class II alleles on the production of aPL in a mouse model of APS. Methods: Three groups of mice, MHC class II–deficient (MHCII−/−) mice, MHCII−/− mice transgenic for human HLA–DQ6 (DQ6), DQ8, or DR4 alleles, and the corresponding wild-type (WT) mouse strains were immunized; half were immunized with human β2-glycoprotein I (β2GPI), and the other half were immunized with control ovalbumin (OVA) protein. Thrombus formation in vivo, tissue factor activity in carotid and peritoneal macrophages, and serum levels of tumor necrosis factor (TNF), IgG anticardiolipin (aCL), antibodies, and anti-OVA antibodies were determined. Results: Immunization with β2GPI induced significant production of aCL and anti-β2GPI in WT mice compared with control mice immunized with OVA (P < 0.001) but diminished aCL (P < 0.001) and anti-β2GPI (P = 0.016) production in MHCII−/− mice. Anti-β2GPI production was fully restored in DQ6 and DQ8 mice, while levels of anti-β2GPI in DR4 mice and aCL in all transgenic lines were only partially restored (P < 0.001 to P < 0.046). Thrombus size in WT mice was twice that in MHCII−/− mice (P < 0.001) but similar to that in all transgenic lines. Carotid and peritoneal macrophage tissue factor levels decreased by >50% in MHCII−/− mice compared with wild-type B6 mice and were restored in DQ8 mice but not DR4 mice or DQ6 mice. TNF levels decreased 4-fold in MHCII−/− mice (P < 0.001) and were not restored in transgenic mice. Conclusion: Our mechanistic study is the first to show that MHC class II alleles influence not only quantitative aPL production but also the pathogenic capacity of induced aPL.

AB - Objective: Both environmental and genetic factors are important in the development of antiphospholipid antibodies (aPL) in patients with antiphospholipid syndrome (APS). Currently, the only available data on predisposing genetic factors have been obtained from epidemiologic studies, without mechanistic evidence. Therefore, we studied the influence of major histocompatibility complex (MHC) class II alleles on the production of aPL in a mouse model of APS. Methods: Three groups of mice, MHC class II–deficient (MHCII−/−) mice, MHCII−/− mice transgenic for human HLA–DQ6 (DQ6), DQ8, or DR4 alleles, and the corresponding wild-type (WT) mouse strains were immunized; half were immunized with human β2-glycoprotein I (β2GPI), and the other half were immunized with control ovalbumin (OVA) protein. Thrombus formation in vivo, tissue factor activity in carotid and peritoneal macrophages, and serum levels of tumor necrosis factor (TNF), IgG anticardiolipin (aCL), antibodies, and anti-OVA antibodies were determined. Results: Immunization with β2GPI induced significant production of aCL and anti-β2GPI in WT mice compared with control mice immunized with OVA (P < 0.001) but diminished aCL (P < 0.001) and anti-β2GPI (P = 0.016) production in MHCII−/− mice. Anti-β2GPI production was fully restored in DQ6 and DQ8 mice, while levels of anti-β2GPI in DR4 mice and aCL in all transgenic lines were only partially restored (P < 0.001 to P < 0.046). Thrombus size in WT mice was twice that in MHCII−/− mice (P < 0.001) but similar to that in all transgenic lines. Carotid and peritoneal macrophage tissue factor levels decreased by >50% in MHCII−/− mice compared with wild-type B6 mice and were restored in DQ8 mice but not DR4 mice or DQ6 mice. TNF levels decreased 4-fold in MHCII−/− mice (P < 0.001) and were not restored in transgenic mice. Conclusion: Our mechanistic study is the first to show that MHC class II alleles influence not only quantitative aPL production but also the pathogenic capacity of induced aPL.

UR - http://www.scopus.com/inward/record.url?scp=85031116785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031116785&partnerID=8YFLogxK

U2 - 10.1002/art.40195

DO - 10.1002/art.40195

M3 - Article

C2 - 28666081

AN - SCOPUS:85031116785

VL - 69

SP - 2052

EP - 2061

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 10

ER -